Iridex (IRIX) Debt to Equity (2020 - 2021)
Iridex's quarterly Debt to Equity came in at $0.09 in Q2 2021, up 18.45% quarter-over-quarter from $0.07 in Q1 2021.
Iridex has reported Debt to Equity for 2 years, with the latest figure at $0.09 in Q2 2021.
- For the quarter ending Q2 2021, Debt to Equity changed N/A year-over-year to $0.09; the trailing twelve-month figure through Apr 2021 stood at $0.09 (changed N/A YoY), and the FY2021 full-year result was $0.07, changed N/A from the prior year.
- Debt to Equity for Q2 2021 stood at $0.09, up from $0.07 in the prior quarter.
- The five-year high for Debt to Equity was $0.09 in Q3 2020, with the low at $0.07 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2021 | 0.09 |
| Jan 2, 2021 | 0.07 |
| Sep 26, 2020 | 0.09 |